{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-365119","form_type":"8-K","ticker":"TNYA","cik":"0001858848","company_name":"Tenaya Therapeutics, Inc.","filed_at":"2021-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.847026+00:00","generated_at":"2026-06-27T23:04:27.473640+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Tenaya Therapeutics appoints Karah Parschauer to Board and Joanna Auch as SVP of People and Culture","bullets":["Board expanded to 10 members; Karah Parschauer appointed as Class I director and audit committee member.","Parschauer receives $35k annual cash retainer, $7.5k audit committee retainer, and ~$320k stock option grant.","Joanna Auch appointed as SVP of People and Culture; previously Head of HR North America at Santen.","Both appointments effective December 22, 2021; Parschauer's term expires at 2022 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-365119","json":"https://secwatch.observer/filing/0001193125-21-365119.json","markdown":"https://secwatch.observer/filing/0001193125-21-365119.md","text":"https://secwatch.observer/filing/0001193125-21-365119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858848/000119312521365119/0001193125-21-365119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858848/000119312521365119/d263572d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T23:04:27.473640+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ada08957c","claim":"Karah Parschauer was appointed as Director at Tenaya Therapeutics, Inc..","evidence_excerpt":"appointed Karah Parschauer to the Board and as a member of the audit committee of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312521365119/0001193125-21-365119-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}